Cargando…

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure

We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fangfang, Zou, Zhengsheng, Shen, Lijun, Wu, Weiwei, Luo, Jiajun, Lankford, Seth, Yang, Yongli, Huang, Huang, You, Shaoli, Zhu, Bing, Li, Jin, Mu, Jinsong, Zhang, Yawei, Xin, Shaojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677318/ https://www.ncbi.nlm.nih.gov/pubmed/33214662 http://dx.doi.org/10.1038/s41598-020-77235-3

Ejemplares similares

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

A new model for identification of HBV-related pre-ACLF
por: Jalan, Rajiv, et al.
Publicado: (2022)

A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients
por: Xia, Qi, et al.
Publicado: (2013)

Comparing CLIF-C ACLF, CLIF-C ACLF(lactate), and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
por: Kuo, Chao-Cheng, et al.
Publicado: (2021)

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
por: Zhang, Xueyun, et al.
Publicado: (2022)

Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF
por: Wu, Zhe-Bin, et al.
Publicado: (2021)

Mean arterial pressure drop is an independent risk factor of hepatorenal syndrome in patients with HBV-ACLF
por: Zheng, Xingrong, et al.
Publicado: (2022)

Identification of a Potential miRNA–mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF
por: Huang, Yandi, et al.
Publicado: (2022)

Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure
por: Wan, Zhihong, et al.
Publicado: (2015)

HMGB1-Induced Hepatocyte Pyroptosis Expanding Inflammatory Responses Contributes to the Pathogenesis of Acute-on-Chronic Liver Failure (ACLF)
por: Hou, Weixin, et al.
Publicado: (2021)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
por: Seeßle, Jessica, et al.
Publicado: (2020)

Serum Lactate Level Predicts Short-Term and Long-Term Mortality of HBV-ACLF Patients: A Prospective Study
por: Nie, Yuan, et al.
Publicado: (2020)

Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF
por: Li, Ning, et al.
Publicado: (2017)

Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells
por: Chen, Linjun, et al.
Publicado: (2023)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle
por: Liang, Jiajun, et al.
Publicado: (2023)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs
por: Liang, Jiajun, et al.
Publicado: (2022)

Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019
por: Liu, Fangfang, et al.
Publicado: (2020)

Multiple organ involvement and ICU considerations for the care of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in children
por: Mataya, Leslie A., et al.
Publicado: (2021)

Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats
por: Fang, Peng, et al.
Publicado: (2021)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure
por: Li, Chen, et al.
Publicado: (2018)

Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure
por: Ramzan, Moazma, et al.
Publicado: (2020)

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
por: Görgülü, Esra, et al.
Publicado: (2022)

Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF
por: Tong, Jingjing, et al.
Publicado: (2022)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF
por: Premkumar, Madhumita, et al.
Publicado: (2021)

Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients
por: Wang, Fei, et al.
Publicado: (2022)

Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)
por: Yang, Jiezuan, et al.
Publicado: (2012)

Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure
por: Engelmann, Cornelius, et al.
Publicado: (2018)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
por: Kaps, L., et al.
Publicado: (2021)

Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes
por: Xia, Lei, et al.
Publicado: (2022)

Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection
por: Li, Weijie, et al.
Publicado: (2014)

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study
por: Li, Peng, et al.
Publicado: (2022)

Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis
por: Tang, Shima, et al.
Publicado: (2023)

Common genetic predisposition for heart failure and cancer
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h8229evgo7lk5tlavi87ig8blh